Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Dow Chemical."
12 result(s) displayed (1 - 12 of 14)
Despite a recession and the vagaries of science and technology, Boston's high-tech corridor continues to thrive. Not that there aren't concerns and anxieties. Continue reading
Posted on May 15, 2009 12:00 PM
Lazard Middle Market's Michael McFadden and David Solomon (pictured). Continue reading
Posted on May 1, 2009 10:21 AM
Dow Chemical used Shearman & Sterling's George Casey (pictured) and Daniel Litowitz on its Morton sale. Continue reading
Posted on April 17, 2009 1:03 PM
They haven't been seen for years, but in some pharma deals, these targeted options are beginning to re-emerge. Continue reading
Posted on April 3, 2009 1:06 PM
Fried Frank's Daniel Bursky advised Paulson & Co. in its role in the Dow-Rohm deal. Continue reading
Posted on March 20, 2009 1:44 PM
Oslers' John Macfarlane was one of Nova's many advisers on its $2.3 billion sale to Ipic. Continue reading
Posted on March 6, 2009 11:06 AM
March 9, 12 and 20 are important days in the M&A world. Continue reading
Posted on March 6, 2009 11:04 AM
2009 has begun better than it might have on the M&A front. Continue reading
Posted on February 6, 2009 1:00 PM
There is demand, there are deals, and there is even money, particularly among strategics. What's lacking in cross-border M&A is animal spirits. It'll take time. Continue reading
Posted on January 23, 2009 12:58 PM
Even deals with committed, fully negotiated and syndicated debt for mergers without financing conditions trade at wide risk premiums. Continue reading
Posted on January 23, 2009 12:42 PM
Dow Chemical finds it's a tough time to try to execute a multideal strategy. Continue reading
Posted on January 9, 2009 2:09 PM
Can the banks drag the BCE deal past Dec. 11? Continue reading
Posted on October 31, 2008 3:49 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
